MIGUEL ANGEL
SANZ ALONSO
CATEDRÁTICO/A DE UNIVERSIDAD
University of Ulm
Ulm, AlemaniaPublicaciones en colaboración con investigadores/as de University of Ulm (8)
2021
-
Midostaurin reduces relapse in FLT3-mutant acute myeloid leukemia: the Alliance CALGB 10603/RATIFY trial
Leukemia, Vol. 35, Núm. 9, pp. 2539-2551
2020
-
Impact of NPM1/FLT3-ITD genotypes defined by the 2017 European LeukemiaNet in patients with acute myeloid leukemia
Blood, Vol. 135, Núm. 5, pp. 371-380
2017
-
Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel
Blood, Vol. 129, Núm. 4, pp. 424-447
2011
-
The European Leukemianet: Achievements and perspectives
Haematologica, Vol. 96, Núm. 1, pp. 156-162
2010
2009
-
Management of acute promyelocytic leukemia: Recommendations from an expert panel on behalf of the European LeukemiaNet
Blood, Vol. 113, Núm. 9, pp. 1875-1891
2006
-
Long-term survival data from a phase 3 study of Filgrastim as an adjunct to chemotherapy in adults with de novo acute myeloid leukemia
Leukemia, Vol. 20, Núm. 3, pp. 404-409
2002
-
Graft-versus-host disease and outcome in HLA-identical sibling transplantations for chronic myeloid leukemia
Blood, Vol. 100, Núm. 12, pp. 3877-3886